Search research articles
Contact Us
Filters
Showing results (1-10 of 4) with videos related to
Page
of 1
Sort By:
Journal of the American Pharmacists Association : Japha
|
January 12, 2017
Adverse event detection using the FDA post-marketing drug safety surveillance system: Cardiotoxicity associated with loperamide abuse and misuse
Kimberley A Swank, Eileen Wu, Cindy Kortepeter, et al.
The Journal of Pediatrics
|
October 18, 2016
Chemical Leukoderma Associated with Methylphenidate Transdermal System: Data From the US Food and Drug Administration Adverse Event Reporting System
Carmen Cheng, Lois La Grenade, Ida-Lina Diak, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
January 14, 2017
Liver injury associated with dimethyl fumarate in multiple sclerosis patients
Monica A Muñoz, Corrinne G Kulick, Cindy M Kortepeter, et al.
The Journal of Clinical Psychiatry
|
September 29, 2011
Vilazodone: clinical basis for the US Food and Drug Administration's approval of a new antidepressant
Thomas P Laughren, Jogarao Gobburu, Robert J Temple, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 4) with videos related to
Sort By:
Page
of 1
Journal of the American Pharmacists Association : Japha
|
January 12, 2017
Adverse event detection using the FDA post-marketing drug safety surveillance system: Cardiotoxicity associated with loperamide abuse and misuse
Kimberley A Swank, Eileen Wu, Cindy Kortepeter, et al.
The Journal of Pediatrics
|
October 18, 2016
Chemical Leukoderma Associated with Methylphenidate Transdermal System: Data From the US Food and Drug Administration Adverse Event Reporting System
Carmen Cheng, Lois La Grenade, Ida-Lina Diak, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
January 14, 2017
Liver injury associated with dimethyl fumarate in multiple sclerosis patients
Monica A Muñoz, Corrinne G Kulick, Cindy M Kortepeter, et al.
The Journal of Clinical Psychiatry
|
September 29, 2011
Vilazodone: clinical basis for the US Food and Drug Administration's approval of a new antidepressant
Thomas P Laughren, Jogarao Gobburu, Robert J Temple, et al.
Page
of 1